WebJan 9, 2024 · Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that … This section contains both current and archived webcasts and presentations of … The Investor Relations website contains information about Daré Bioscience's … WebMar 30, 2024 · Dare Bioscience press release ( NASDAQ: DARE ): FY GAAP EPS of -$0.37 misses by $0.07. Revenue of $10M in-line. Cash and cash equivalents: $34.7 million at December 31, 2024, compared to $51.7...
Did you know?
WebPress Release. Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that Support the Potential of DARE ... WebMar 29, 2024 · Scrip Asks…What Does 2024 Hold For Biopharma? Part 10: Diversity, Equity And Inclusion (Subscription required)
WebJul 26, 2024 · SAN DIEGO, July 26, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that David Friend, PhD, the company’s Chief Scientific Officer, will present data from preclinical and clinical studies related to DARE-BV1 at the 2024 Controlled Release Society (CRS) … WebApr 1, 2024 · SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it received a Notice of Award of $730,722 in a grant supporting the Ovaprene® postcoital test (PCT) clinical study research from the Eunice Kennedy Shriver National Institute of Child Health …
WebMar 31, 2024 · Press Release Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV) 03-31-2024 at 7:00 AM EDT PDF Version An estimated 21 million American women experience … WebNov 15, 2024 · SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it has received a grant from the Bill & Melinda Gates Foundation (the foundation) of $584,986 to support activities related to development of a vaginal thermosetting gel formulation for the …
WebJul 23, 2024 · We are accelerating innovation in women’s health. At Daré, we believe women’s health is an important therapeutic area that deserves dramatically increased …
WebDec 31, 2024 · SAN DIEGO, March 23, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, March 30, 2024, to review its financial results for the year ended December 31, 2024 and to provide … slt1w12revdp01/evidence/recordingWebApr 26, 2024 · SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that data from the DARE-BVFREE Phase 3 study of DARE-BV1, a thermosetting vaginal gel for the treatment of bacterial vaginosis, will be presented at the 2024 American College of … soilfix asbestosWebMar 24, 2024 · Daré Bioscience Announces Interim Analysis of Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder. … soil filters waterWebSep 1, 2024 · SAN DIEGO, Sept. 01, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that David Friend, PhD, the company’s Chief Scientific Officer, will present data from the company’s Phase 1 pharmacokinetic and safety study of DARE-HRT1 at the European Menopause … soil finisher vs field cultivatorsl t20 match sheduleWebAug 9, 2024 · SAN DIEGO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA)... slt-20-50-a-cc-bWebFeb 28, 2024 · Scrip Asks…What Does 2024 Hold For Biopharma? Part 7: Clinical Trial Trends (Subscription required) soil flipper machine